NDC11 50881000714
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 50881-0007-14 | 50881-0007 |
| 50881-007-14 | 50881-007 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OPZELURA | RUXOLITINIB | Incyte Corporation | 24da5509-6631-4795-9d42-273faecd08e7 | 2026-06-30 | Boxed warning, Warnings, Adverse reactions | 50881-007-14 50881-007 50881000714 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.